Financial News
All News about Pliant Therapeutics Inc
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/01/plrx_1.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/01/3628710.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Pliant Therapeutics
April 13, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Pliant Therapeutics
March 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
9 Analysts Have This to Say About Pliant Therapeutics
March 10, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/718159/scientists-in-a-lab.jpg)
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2023/05/01/first_republic_bank_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_8174.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/02/24/plrx_logo_light__80fb665f83fa74105bed57d71e91acb5.png?width=1200&height=800&fit=crop)
Novartis Takes Down $80M NASH Pact With Pliant Therapeutics
February 24, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Pliant Therapeutics to Participate in Upcoming Investor Events
February 07, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_75217473_S.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/07141511-d0cc-4c2f-b6f6-2812f8600f31/small/pliant-primarysubtitle-color-rgb-jpg.jpg)
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.